Attached files

file filename
EX-32.1 - SECTION 906 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL - PEAK PHARMACEUTICALS, INC.exhibit_32-1.htm
EX-31.2 - SECTION 302 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL - PEAK PHARMACEUTICALS, INC.exhibit_31-2.htm
EX-31.1 - SECTION 302 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL - PEAK PHARMACEUTICALS, INC.exhibit_31-1.htm
10-Q - PEAK PHARMACEUTICALS, INC. 10-Q - PEAK PHARMACEUTICALS, INC.peak_10q-17233.htm
 
Exhibit 32.2
 
CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
The undersigned, Neil Reithinger, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(a)
The quarterly report on Form 10-Q of Peak Pharmaceuticals, Inc. for the quarter ended December 31, 2016 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(b)
Information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
Date:
 
September 12, 2017
 
 
 
By:
 
/s/ Neil Reithinger
Name:
 
Neil Reithinger
Title:
 
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)